SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
Quidel (NASDAQ:QDEL) stated Thursday that it expects its Q1 2022 revenue to range between $990M-$1B, reflecting growth of 164%-166% Y/Y. The preliminary estimate accounts for COVID-19 product revenue ...
(Reuters) - The U.S. Food and Drug Administration (FDA) on Saturday approved emergency use authorization (EUA) to Quidel Corp for the first COVID-19 antigen test. The emergency use authorization was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback